Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohan Chi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|September 21, 2022
BOB: Bayesian optimal design for biosimilar trials with co-primary endpointsXiaohan Chi, Zhangsheng Yu, Ruitao Lin
Therapeutic Innovation & Regulatory Science|August 20, 2025
BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug CombinationsXiaohan Chi, Ying Yuan, Ruitao Lin
Biometrics|June 24, 2025
COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapiesXiaohan Chi, Ruitao Lin, Ying Yuan
Biometrical Journal. Biometrische Zeitschrift|February 17, 2024
A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpointsXiaohan Chi, Ying Yuan, Zhangsheng Yu, et al.
Scientific Reports|February 11, 2026
Lipid metabolism classification of gliomasShaohua Tu, Peng Zhang, Xiaohan Chi, et al.
Frontiers in Oncology|June 6, 2022
Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of HSPPC-96 Vaccination in Treating GlioblastomaXiaohan Chi, Yi Wang, Chunzhao Li, et al.
Frontiers in Oncology|July 29, 2022
Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 VaccinationYi Wang, Chunzhao Li, Xiaohan Chi, et al.
Journal of Neuro-Oncology|May 24, 2024
Constitutive type-1 interferons signaling activity in malignant gliomasChunzhao Li, Lang Long, Yi Wang, et al.
Journal of Neuro-Oncology|October 29, 2024
Expression features of targets for anti-glioma CAR-T cell immunotherapyPeng Zhang, Chunzhao Li, Yi Wang, et al.
Neuroimage|November 28, 2024
A first-in-human application of OPM-MEG for localizing motor activity area: Compared to functional MRITai Sun, Xiaohan Chi, Yuming Peng, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|September 21, 2022
BOB: Bayesian optimal design for biosimilar trials with co-primary endpointsXiaohan Chi, Zhangsheng Yu, Ruitao Lin
Therapeutic Innovation & Regulatory Science|August 20, 2025
BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug CombinationsXiaohan Chi, Ying Yuan, Ruitao Lin
Biometrics|June 24, 2025
COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapiesXiaohan Chi, Ruitao Lin, Ying Yuan
Biometrical Journal. Biometrische Zeitschrift|February 17, 2024
A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpointsXiaohan Chi, Ying Yuan, Zhangsheng Yu, et al.
Scientific Reports|February 11, 2026
Lipid metabolism classification of gliomasShaohua Tu, Peng Zhang, Xiaohan Chi, et al.
Frontiers in Oncology|June 6, 2022
Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of HSPPC-96 Vaccination in Treating GlioblastomaXiaohan Chi, Yi Wang, Chunzhao Li, et al.
Frontiers in Oncology|July 29, 2022
Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 VaccinationYi Wang, Chunzhao Li, Xiaohan Chi, et al.
Journal of Neuro-Oncology|May 24, 2024
Constitutive type-1 interferons signaling activity in malignant gliomasChunzhao Li, Lang Long, Yi Wang, et al.
Journal of Neuro-Oncology|October 29, 2024
Expression features of targets for anti-glioma CAR-T cell immunotherapyPeng Zhang, Chunzhao Li, Yi Wang, et al.
Neuroimage|November 28, 2024
A first-in-human application of OPM-MEG for localizing motor activity area: Compared to functional MRITai Sun, Xiaohan Chi, Yuming Peng, et al.
Pageof 2